Moderna's 177% stock surge followed its mRNA cancer vaccine success, but CEO Stéphane Bancel says China's biotechnology investments pose a threat.
Market Samachar is a news aggregator. This article was originally published by Fox Business. Tap the button above to read the full story on their site.